News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
314,030 Results
Type
Article (17416)
Company Profile (49)
Press Release (296562)
Multimedia
Podcasts (43)
Webinars (7)
Section
Business (81694)
Career Advice (697)
Deals (15082)
Drug Delivery (42)
Drug Development (43447)
Employer Resources (75)
FDA (7703)
Job Trends (6518)
News (149727)
Policy (14113)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (2)
Academia (1465)
Academic (1)
Accelerated approval (26)
Adcomms (13)
Allergies (89)
Alliances (21810)
ALS (124)
Alzheimer's disease (850)
Antibody-drug conjugate (ADC) (240)
Approvals (8148)
Artificial intelligence (398)
Autoimmune disease (159)
Automation (33)
Bankruptcy (124)
Best Places to Work (5557)
BIOSECURE Act (6)
Biosimilars (150)
Biotechnology (31)
Bladder cancer (157)
Brain cancer (44)
Breast cancer (489)
Cancer (3686)
Cardiovascular disease (303)
Career advice (608)
Career pathing (18)
CAR-T (169)
CDC (34)
Celiac Disease (2)
Cell therapy (494)
Cervical cancer (30)
Clinical research (39480)
Collaboration (1246)
Company closure (2)
Compensation (569)
Complete response letters (36)
COVID-19 (2300)
CRISPR (70)
C-suite (618)
Cystic fibrosis (67)
Data (5270)
Decentralized trials (1)
Denatured (11)
Depression (92)
Dermatology (55)
Diabetes (322)
Diagnostics (3435)
Digital health (29)
Diversity (9)
Diversity, equity & inclusion (29)
Drug discovery (179)
Drug pricing (80)
Drug shortages (20)
Duchenne muscular dystrophy (156)
Earnings (34214)
Editorial (31)
Employer branding (6)
Employer resources (68)
Events (45602)
Executive appointments (681)
FDA (10081)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (16)
Funding (1003)
Gene editing (125)
Generative AI (26)
Gene therapy (397)
GLP-1 (537)
Government (2202)
Grass and pollen (4)
Guidances (265)
Healthcare (8660)
HIV (65)
Huntington's disease (31)
IgA nephropathy (47)
Immunology and inflammation (109)
Immuno-oncology (46)
Indications (115)
Infectious disease (2541)
Inflammatory bowel disease (116)
Inflation Reduction Act (8)
Influenza (109)
Intellectual property (124)
Interviews (115)
IPO (6300)
IRA (25)
Job creations (1238)
Job search strategy (524)
JPM (19)
Kidney cancer (14)
Labor market (31)
Layoffs (147)
Leadership (21)
Legal (2932)
Liver cancer (55)
Longevity (13)
Lung cancer (510)
Lymphoma (285)
Machine learning (33)
Management (23)
Manufacturing (507)
MASH (116)
Medical device (5619)
Medtech (5683)
Mergers & acquisitions (9569)
Metabolic disorders (774)
mRNA (104)
Multiple sclerosis (123)
NASH (16)
Neurodegenerative disease (209)
Neuropsychiatric disorders (47)
Neuroscience (1691)
NextGen: Class of 2026 (2602)
Non-profit (2167)
Now hiring (20)
Obesity (317)
Opinion (153)
Ovarian cancer (140)
Pain (146)
Pancreatic cancer (179)
Parkinson's disease (186)
Partnered (16)
Patents (220)
Patient recruitment (393)
Peanut (30)
People (26784)
Pharmaceutical (13)
Pharmacy benefit managers (18)
Phase 1 (10447)
Phase 2 (17037)
Phase 3 (14867)
Pipeline (5341)
Policy (138)
Postmarket research (1574)
Preclinical (4002)
Press Release (59)
Prostate cancer (206)
Psychedelics (25)
Radiopharmaceuticals (146)
Rare diseases (581)
Real estate (2350)
Recruiting (26)
Regulatory (12063)
Reports (19)
Research institute (1392)
Resumes & cover letters (92)
Rett syndrome (32)
RNA editing (10)
RSV (61)
Schizophrenia (91)
Series A (175)
Series B (123)
Service/supplier (4)
Sickle cell disease (61)
Special edition (7)
Spinal muscular atrophy (98)
Sponsored (17)
Startups (1521)
State (1)
Stomach cancer (6)
Supply chain (59)
Tariffs (22)
The Weekly (32)
Vaccines (713)
Venture capital (38)
Weight loss (184)
Women's health (65)
Worklife (9)
Date
Last 7 days (397)
Last 30 days (1872)
Last 365 days (16930)
2026 (7247)
2025 (17511)
2024 (16483)
2023 (17151)
2022 (23078)
2021 (25571)
2020 (25105)
2019 (20213)
2018 (15334)
2017 (14247)
2016 (13729)
2015 (16415)
2014 (11718)
2013 (9525)
2012 (10501)
2011 (11065)
2010 (10286)
Location
Africa (370)
Alabama (27)
Alaska (4)
Arizona (113)
Arkansas (7)
Asia (18925)
Australia (3144)
California (6886)
Canada (1869)
China (776)
Colorado (308)
Connecticut (368)
Delaware (301)
Europe (48017)
Florida (851)
Georgia (258)
Hawaii (3)
Idaho (21)
Illinois (633)
India (57)
Indiana (266)
Iowa (13)
Japan (433)
Kansas (58)
Kentucky (25)
Louisiana (22)
Maine (18)
Maryland (749)
Massachusetts (5026)
Michigan (136)
Minnesota (338)
Mississippi (1)
Missouri (69)
Montana (7)
Nebraska (13)
Nevada (92)
New Hampshire (90)
New Jersey (3497)
New Mexico (25)
New York (2132)
North Carolina (1713)
North Dakota (11)
Northern California (3423)
Ohio (175)
Oklahoma (8)
Oregon (15)
Pennsylvania (1214)
Puerto Rico (9)
Rhode Island (20)
South America (575)
South Carolina (17)
South Dakota (1)
Southern California (2673)
Tennessee (102)
Texas (1055)
United States (26633)
Utah (127)
Virginia (174)
Washington D.C. (27)
Washington State (559)
West Virginia (2)
Wisconsin (113)
Wyoming (2)
314,030 Results for "pharming group n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharming Group announces the 2026 Annual General Meeting of Shareholders
April 16, 2026
·
1 min read
Press Releases
Pharming Group to participate in April 2026 investor conferences
April 7, 2026
·
1 min read
Press Releases
Pharming Group to report first quarter 2026 financial results and provide business update on May 7
April 23, 2026
·
1 min read
Press Releases
Pharming Group announces the filing of its 2025 Annual Report and Form 20-F
April 2, 2026
·
1 min read
Press Releases
Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
May 7, 2026
·
9 min read
Press Releases
Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
May 7, 2026
·
21 min read
Press Releases
Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 17, 2026
·
1 min read
Press Releases
Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older
March 24, 2026
·
8 min read
Press Releases
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
March 27, 2026
·
8 min read
Press Releases
Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12
February 26, 2026
·
1 min read
1 of 31,403
Next
